|
| dbGaP Submitter Subject ID (ID2) | Coriell Sample ID | Consent | Control | Gender | Race | Age | Baseline Max AMD Severity | Final Max AMD Severity |
| AR2_0134 | ED148484 | General Research Use | No | Female | White | 63 | 8 - AREDS AMD Severity Scale Step 7 | 8 - AREDS AMD Severity Scale Step 8 |
| AR2_0274 | ED149668 | General Research Use | No | Female | White | 58 | 8 - AREDS AMD Severity Scale Step 8 | 8 - AREDS AMD Severity Scale Step 8 |
| AR2_0294 | ED148943 | General Research Use | No | Female | White | 55 | 8 - AREDS AMD Severity Scale Step 6 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_0506 | ED149124 | General Research Use | No | Male | White | 74 | 8 - AREDS AMD Severity Scale Step 7 | 10 - Central GA |
| AR2_0758 | ED149224 | General Research Use | No | Male | White | 79 | 8 - AREDS AMD Severity Scale Step 4 | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_0940 | ED149377 | General Research Use | No | Male | White | 77 | 8 - AREDS AMD Severity Scale Step 7 | 10 - Central GA |
| AR2_1012 | ED148313 | General Research Use | No | Female | White | 85 | 8 - AREDS AMD Severity Scale Step 8 | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_1057 | ED148057 | General Research Use | No | Male | White | 58 | 8 - AREDS AMD Severity Scale Step 7 | 8 - AREDS AMD Severity Scale Step 8 |
| AR2_1298 | ED149790 | General Research Use | No | Female | White | 65 | 8 - AREDS AMD Severity Scale Step 8 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_1343 | ED149369 | General Research Use | No | Male | White | 79 | 8 - AREDS AMD Severity Scale Step 8 | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_1763 | ED148479 | General Research Use | No | Male | White | 76 | 8 - AREDS AMD Severity Scale Step 6 | 10 - Central GA |
| AR2_1863 | ED148896 | General Research Use | No | Male | White | 77 | 8 - AREDS AMD Severity Scale Step 8 | 10 - Central GA |
| AR2_1976 | ED149376 | General Research Use | No | Male | White | 73 | 8 - AREDS AMD Severity Scale Step 7 | 9 - AREDS AMD Severity Scale Step 9 |
| AR2_2033 | ED149227 | General Research Use | No | Male | White | 69 | 8 - AREDS AMD Severity Scale Step 7 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_2119 | ED149373 | General Research Use | No | Female | White | 67 | 8 - AREDS AMD Severity Scale Step 8 | 9 - AREDS AMD Severity Scale Step 9 |
| AR2_2160 | ED149943 | General Research Use | No | Female | White | 66 | 8 - AREDS AMD Severity Scale Step 8 | 8 - AREDS AMD Severity Scale Step 8 |
| AR2_2287 | ED148200 | General Research Use | No | Female | White | 53 | 8 - AREDS AMD Severity Scale Step 7 | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_2454 | ED149179 | General Research Use | No | Female | White | 71 | 8 - AREDS AMD Severity Scale Step 8 | 8 - AREDS AMD Severity Scale Step 8 |
| AR2_2498 | ED149382 | General Research Use | No | Male | White | 81 | 8 - AREDS AMD Severity Scale Step 8 | 10 - Central GA |
| AR2_2507 | ED149862 | General Research Use | No | Male | White | 76 | 8 - AREDS AMD Severity Scale Step 6 | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |